Advertisement
Advertisement
IMRX
Immuneering Corporation Class A Common Stock
4.37
USDSponsored
+0.04
+1.04%
Jul 27, 13:56 UTC -4
Open
IMRX Earnings Reports
Positive Surprise Ratio
IMRX beat 15 of 20 last estimates.
75%
Next Report
Date of Next Report
Aug 12, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/-$0.27
Implied change from Q1 26 (Revenue/ EPS)
--
/+28.57%
Implied change from Q2 25 (Revenue/ EPS)
--
/-32.50%
Immuneering Corporation Class A Common Stock earnings per share and revenue
On May 15, 2026, IMRX reported earnings of -0.21 USD per share (EPS) for Q1 26, beating the estimate of -0.25 USD, resulting in a 18.29% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +0.39% price change (close before vs. close after earnings).
Looking ahead to Q2 26, -- analysts forecast an EPS of -0.27 USD, with revenue projected to reach -- USD, implying an increase of 28.57% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
NovoCure Limited Ordinary Shares
Report Date
Jul 23, 2026 For Q2 26
Estimate
-$0.33
Actual
-$0.13
Surprise
+61.70%
DBV Technologies S.A.
Report Date
Jul 16, 2026 For Q2 26
Estimate
-$0.10
Actual
-$0.60
Surprise
-494.06%
argenx SE - ADR
Report Date
Jul 23, 2026 For Q2 26
Estimate
$6.29
Actual
$7.32
Surprise
+16.38%
Lexaria Bioscience Corp. Common Stock
Report Date
Jul 13, 2026 For Q3 26
Estimate
-$0.08
Actual
-$0.08
Surprise
+7.73%
VivoSim Labs, Inc. Common Stock
Report Date
Jul 14, 2026 For Q4 25
Estimate
-$0.19
Actual
-$2.21
Surprise
-1,040.35%
FAQ
What were Immuneering Corporation Class A Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Immuneering Corporation Class A Common Stock reported EPS of -$0.21, beating estimates by 18.29%, and revenue of $0.00, 0% as expectations.
How did the market react to Immuneering Corporation Class A Common Stock's Q1 2026 earnings?
The stock price moved up 0.39%, changed from $5.14 before the earnings release to $5.16 the day after.
When is Immuneering Corporation Class A Common Stock expected to report next?
The next earning report is scheduled for Aug 12, 2026.
What are the forecasts for Immuneering Corporation Class A Common Stock's next earnings report?
Based on --
analysts, Immuneering Corporation Class A Common Stock is expected to report EPS of -$0.27 and revenue of -- for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement